117 related articles for article (PubMed ID: 18091378)
21. Immunohistochemical expression of YKL-40 in peritoneal endometriosis.
Kim PJ; Hong DG; Park JY; Cho YL; Park IS; Lee YS
Gynecol Endocrinol; 2010 Jan; 26(1):58-62. PubMed ID: 19701838
[TBL] [Abstract][Full Text] [Related]
22. Early detection and prognosis of ovarian cancer using serum YKL-40.
Dupont J; Tanwar MK; Thaler HT; Fleisher M; Kauff N; Hensley ML; Sabbatini P; Anderson S; Aghajanian C; Holland EC; Spriggs DR
J Clin Oncol; 2004 Aug; 22(16):3330-9. PubMed ID: 15310777
[TBL] [Abstract][Full Text] [Related]
23. High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement.
Nordenbaek C; Johansen JS; Halberg P; Wiik A; Garbarsch C; Ullman S; Price PA; Jacobsen S
Scand J Rheumatol; 2005; 34(4):293-7. PubMed ID: 16195162
[TBL] [Abstract][Full Text] [Related]
24. Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer.
Yamac D; Ozturk B; Coskun U; Tekin E; Sancak B; Yildiz R; Atalay C
Adv Ther; 2008 Aug; 25(8):801-9. PubMed ID: 18670741
[TBL] [Abstract][Full Text] [Related]
25. Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis.
Savage K; Lambros MB; Robertson D; Jones RL; Jones C; Mackay A; James M; Hornick JL; Pereira EM; Milanezi F; Fletcher CD; Schmitt FC; Ashworth A; Reis-Filho JS
Clin Cancer Res; 2007 Jan; 13(1):90-101. PubMed ID: 17200343
[TBL] [Abstract][Full Text] [Related]
26. Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas.
Lebeau A; Nerlich AG; Sauer U; Lichtinghagen R; Löhrs U
Anticancer Res; 1999; 19(5B):4257-64. PubMed ID: 10628384
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers.
Shao R; Cao QJ; Arenas RB; Bigelow C; Bentley B; Yan W
Br J Cancer; 2011 Oct; 105(8):1203-9. PubMed ID: 21934681
[TBL] [Abstract][Full Text] [Related]
28. Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma.
Tanwar MK; Gilbert MR; Holland EC
Cancer Res; 2002 Aug; 62(15):4364-8. PubMed ID: 12154041
[TBL] [Abstract][Full Text] [Related]
29. Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast.
Clezardin P; Frappart L; Clerget M; Pechoux C; Delmas PD
Cancer Res; 1993 Mar; 53(6):1421-30. PubMed ID: 7680285
[TBL] [Abstract][Full Text] [Related]
30. Regulation of YKL-40 production by human articular chondrocytes.
Johansen JS; Olee T; Price PA; Hashimoto S; Ochs RL; Lotz M
Arthritis Rheum; 2001 Apr; 44(4):826-37. PubMed ID: 11315922
[TBL] [Abstract][Full Text] [Related]
31. Expression of c-kit proto-oncogene product in breast tissue.
Yared MA; Middleton LP; Meric F; Cristofanilli M; Sahin AA
Breast J; 2004; 10(4):323-7. PubMed ID: 15239791
[TBL] [Abstract][Full Text] [Related]
32. Expression and localization of homeodomain proteins DLX4/HB9 in normal and malignant human breast tissues.
Neufing PJ; Kalionis B; Horsfall DJ; Ricciardelli C; Stahl J; Vivekanandan S; Raymond W; Tilley WD
Anticancer Res; 2003; 23(2B):1479-88. PubMed ID: 12820413
[TBL] [Abstract][Full Text] [Related]
33. YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma.
Pelloski CE; Mahajan A; Maor M; Chang EL; Woo S; Gilbert M; Colman H; Yang H; Ledoux A; Blair H; Passe S; Jenkins RB; Aldape KD
Clin Cancer Res; 2005 May; 11(9):3326-34. PubMed ID: 15867231
[TBL] [Abstract][Full Text] [Related]
34. YKL-40 tissue expression and plasma levels in patients with ovarian cancer.
Høgdall EV; Ringsholt M; Høgdall CK; Christensen IJ; Johansen JS; Kjaer SK; Blaakaer J; Ostenfeld-Møller L; Price PA; Christensen LH
BMC Cancer; 2009 Jan; 9():8. PubMed ID: 19134206
[TBL] [Abstract][Full Text] [Related]
35. High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival.
Cintin C; Johansen JS; Christensen IJ; Price PA; Sørensen S; Nielsen HJ
Cancer; 2002 Jul; 95(2):267-74. PubMed ID: 12124825
[TBL] [Abstract][Full Text] [Related]
36. Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma.
Schmidt H; Johansen JS; Gehl J; Geertsen PF; Fode K; von der Maase H
Cancer; 2006 Mar; 106(5):1130-9. PubMed ID: 16456816
[TBL] [Abstract][Full Text] [Related]
37. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
38. High serum YKL-40 level in patients with small cell lung cancer is related to early death.
Johansen JS; Drivsholm L; Price PA; Christensen IJ
Lung Cancer; 2004 Dec; 46(3):333-40. PubMed ID: 15541818
[TBL] [Abstract][Full Text] [Related]
39. YKL-40 in giant cells and macrophages from patients with giant cell arteritis.
Johansen JS; Baslund B; Garbarsch C; Hansen M; Stoltenberg M; Lorenzen I; Price PA
Arthritis Rheum; 1999 Dec; 42(12):2624-30. PubMed ID: 10616010
[TBL] [Abstract][Full Text] [Related]
40. Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells.
Mylin AK; Rasmussen T; Johansen JS; Knudsen LM; Nørgaard PH; Lenhoff S; Dahl IM; Johnsen HE;
Eur J Haematol; 2006 Nov; 77(5):416-24. PubMed ID: 16930142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]